Abstract | DNA methylation is one of the best-characterized epigenetic modifications and has been implicated in numerous biological processes, including transposable element silencing, genomic imprinting and X chromosome inactivation. Compared with other epigenetic modifications, DNA methylation is thought to be relatively stable. Despite its role in long-term silencing, DNA methylation is more dynamic than originally thought as active DNA demethylation has been observed during specific stages of development. In the past decade, many enzymes have been proposed to carry out active DNA demethylation and growing evidence suggests that, depending on the context, this process may be achieved by multiple mechanisms. Insight into how DNA methylation is dynamically regulated will broaden our understanding of epigenetic regulation and have great implications in somatic cell reprogramming and regenerative medicine. 
Eukaryotic chromatin contains a wealth of information required for the growth and development of a multi cellular organism. This information is not only stored genetically in the DNA sequence itself but also epigeneti cally through DNA methylation and posttranslational modifications of histone proteins 1, 2 . Although every nucleotide in the genome has the potential to be trans cribed 3 , the presence or absence of specific epigenetic marks influences gene expression, resulting in a trans criptional programme that specifies for a particular cell type. For example, in embryonic stem (ES) cells, active gene expression marks are found at pluripotent genes and repressive marks are found at lineagespecific genes. Thus, different cell types can be defined by their epigenetic and gene expression profiles.
During development, these transcriptional pro grammes undergo dynamic changes that ultimately lead to the production of distinct cell types and tissues that make up an organism. Accommodating such a transcriptional programme requires an epigenome that is both dynamic and flexible. Furthermore, the diversity of genetic material to be regulated necessitates the use of marks corresponding to shortterm and longterm epigenetic memory, depending on the transcriptional requirements of the cell (as well as those of future generations). Developmental genes that are needed during the later stages of develop ment are trans iently held in a repressed state during early development. This is achieved through shortterm epi genetic marks such as histone modifications, which can be removed before or within a few cell divisions.
By contrast, other regions of the genome are marked with epigenetic information that is stably maintained and heritable after many cell divisions. For example, imprinted genes, transposons and the inactive X chromosome require longterm silencing that is sustained throughout the development and lifespan of an organism. This is generally achieved by DNA methylation, an epigenetic mark that refers to the addition of a methyl group to the fifth carbon of base C. Because DNA methylation provides heritable, longterm silencing that is crucial for an organism, aber rant DNA methylation has been associated with cancer, imprintingrelated diseases and psychiatric disorders [4] [5] [6] [7] . In mammals, DNA methylation occurs predominantly in the context of CpG (C followed by G) dinucleotides, whereas DNA methylation in plants can occur at C bases in diverse sequence contexts 8 . The enzymes responsible for this modification, DNA methyltransferases (DNMTs), are well characterized and conserved in mammals and plants 8 . DNMTs fall under two categories: de novo and mainte nance 9 . Patterns of DNA methylation are initially estab lished by the de novo DNA methyltransferases DNMT3A and DNMT3B during the blastocyst stage of embryonic development 10, 11 (FIG. 1 ). These methyl marks are then faithfully maintained during cell divisions through the action of the maintenance methyltransferase, DNMT1, which has a preference for hemi-methylated DNA [12] [13] [14] . Both the establishment and maintenance of DNA methylation patterns are crucial for development as mice deficient in DNMT3B or DNMT1 are embryonic lethal 11, 15 and DNMT3Anull mice die by 4 weeks of age 11 .
Imprinted gene
A gene that is expressed in a parent-of-origin-specific manner.
Inactive X chromosome
The copy of X chromosome that is silenced in female chromosomes in order to equalize the expression of genes located in the X chromosome in males and females.
Polar body
The structure that is extruded from the oocyte during meiosis and contains one haploid set of chromosomes.
Parthenogenesis
The production of a diploid offspring from two sets of haploid maternal gametes and no paternal contribution.
Gynogenesis
Parthenogenesis in which the embryo contains only maternal chromosomes owing to the failure of the sperm to fuse with the egg nucleus.
Although DNA methylation has been viewed as a stable epigenetic mark, studies in the past decade have revealed that this modification is not as static as once thought. In fact, loss of DNA methylation, or DNA demethylation, has been observed in specific contexts (see below) and can occur through active or passive mecha nisms (FIG. 1) . Active DNA demethylation is the enzymatic process that results in the removal of the methyl group from 5methyl cytosine (5meC) by breaking a carboncarbon bond. By contrast, passive DNA demethylation refers to the loss of the methyl group from 5meC when DNMT1 is inhibited or absent during successive rounds of DNA replication. whereas passive DNA demethyla tion is generally understood and accepted, the subject of active DNA demethylation has been controversial 16 .
In this review, we explore what is known about active DNA demethylation and the disputes that are embedded in this field. First, we describe the contexts in which DNA demethylation has been observed and discuss the evidence that supports an active mechanism. we then present the many enzymes that have been proposed to carry out active DNA demethylation. we conclude by discussing emerging themes and highlighting the remaining questions in this exciting field.
Evidence for active DNA demethylation Even though DNA methylation contributes to stable, longterm and heritable silencing, it has become appar ent that in some instances DNA methylation levels can rapidly change by mechanisms involving active DNA de methylation. Genomewide and genespecific demethyl ation events have both been observed, but current evidence suggests that the former only occurs at specific times during early development, whereas the latter occurs in somatic cells responding to specific signals.
Genome-wide DNA demethylation of paternal pronuclei. Prior to fertilization, mammalian gametes are at different stages of the cell cycle and their genomes are organized differently. The egg is meiotically arrested at metaphase II, resulting in a diploid genome that is packaged with histones. Mature sperm, however, have completed meiosis, but their haploid genomes are packaged with protamines instead of histones. when a sperm penetrates the zona pellucida to fertilize the egg, both gametes undergo rapid changes. The egg completes its second meiosis resulting in the extrusion of one copy of the genome as the polar body; the sperm reorganizes its genomic DNA by replacing protamines with histone proteins.
Shortly after the protamine-histone exchange, the spermderived paternal pronucleus undergoes genome wide DNA demethylation 17, 18 , an event that occurs quite rapidly within 4-8 hours postfertilization (FIG. 2a) . Although there are some disputes regarding the timing and synchrony of DNA replication in the zygote [19] [20] [21] [22] [23] [24] [25] , loss of DNA methylation is seen before the completion of the first cell division. Thus, it is unlikely that a passive demethylation mechanism is the cause for this observ ation. Furthermore, when zygotes were treated with the replication inhibitor aphidicolin, paternal genome demethylation was still detected 17, 26 , further supporting an active demethylation mechanism.
Paternal genome demethylation has been observed in many mammalian organisms, including human, mouse, rat, bovine and pig 17, 18, 27, 28 , but seems to be absent from others, such as sheep 29 . when sheep sperm are injected into mouse oocytes, demethylation is seen in the sheep derived paternal genome 30 , suggesting that the demethyl ating factor or factors are contributed by the oocyte. However, sheep oocytes injected with mouse sperm also resulted in demethylation of the mousederived paternal genome 30 . Although this occurs to a lesser extent com pared to mouse oocytes, it is likely that factors present in the sperm or features unique to the paternal genome also contribute to demethylation. Consistent with this notion, mouse oocytes can demethylate multiple male pronuclei 31 , but are incapable of demethylating the additional maternal genome in parthenogenetic, gynogenetic and digynic triploid zygotes 32 . Although immunostaining studies suggest that demethylation occurs globally, bisulphite sequencing indi cates that some genomic regions are resistant to such a wave of demethylation. These genomic regions include imprinting control regions 33 , intracisternal Aparticle (IAP) retrotransposons 34 and centric and pericentric hetero chromatin 31, 35 . It is not clear why these genomic When DNA replication and cell division occur, these methyl marks are maintained in daughter cells by the maintenance methyltransferase, DNMT1, which has a preference for hemi-methylated DNA. If DNMT1 is inhibited or absent when the cell divides, the newly synthesized strand of DNA will not be methylated and successive rounds of cell division will result in passive demethylation. By contrast, active demethylation can occur through the enzymatic replacement of 5-methylcytosine (5meC) with C. 
Bisulphite sequencing
A technique in which the treatment of DNA with bisulphite, which converts C to U but does not modify meC, is used to determine the DNA methylation pattern.
Blastocyst
An embryonic stage that is characterized by the formation of the first definitive lineages.
regions are resistant to this wave of DNA demethylation, but one possibility is that methylation of these regions may be required to ensure transcriptional repression and chromosomal stability. Additionally, the maternal genome remains methylated during this time even though it is exposed to the same cytoplasmic factors. Insight into how some regions in the paternal genome are targeted for DNA demethylation whereas other regions are resistant may also provide clues as to how the maternal genome is protected from active demethylation
. The significance of zygotic paternal genome DNA demethylation is unclear at present. Genomewide demethylation may facilitate transcriptional activation of the paternal genome 36 , which has been reported to occur before transcriptional activation of the maternal genome in some species 37 . Although some transposable elements and repeat sequences have been identified to be resistant to DNA demethylation, it is likely that others are still targets of DNA demethylation, given that these types of sequences account for half of the genome. whether demethylation of transposable elements and repeat sequences results in their reactivation and, if so, what the significance of their reactivation is remains to be determined.
Genome-wide DNA demethylation of primordial germ cells. After fertilization, the onecell zygote undergoes several cell divisions that ultimately lead to formation of the blastocyst. During this developmental period, the maternal genome undergoes passive DNA demethyla tion (FIG. 2a) -a gradual loss of DNA methylation occurs with each cell division 38 in a replicationdependent manner 39 . Consistent with this, maternally contributed DNMT1 (also known as DNMT1o) is excluded from the nucleus 40 . Although passive DNA demethylation seems to affect a large part of the genome, imprinted genes still retain their methylation marks. recent genetic studies indicate that maternal and zygotic DNMT1 (ReF. 41) and the zinc finger protein ZFP57 (ReF. 42) are required to maintain the DNA methylation imprints during preimplantation development. Shortly after a sperm fertilizes an egg, the paternal genome rapidly undergoes genome-wide active DNA demethylation and remains demethylated following multiple rounds of cell division. During this time, the maternal genome experiences gradual, passive demethylation. De novo methylation patterns are established by the DNA methyltransferases DNMT3A and DNMT3B during the development of the blastocyst. b | Active demethylation in primordial germ cells (PGCs). After implantation of the blastocyst at embryonic day 7.5 (E7.5), the extraembryonic ectoderm (ExE) and visceral endoderm (VE) produce signals that specify a subset of epiblast cells (Epi) to become PGCs. This process requires two key transcription factors, BLIMP1 (also known as PR domain zinc finger protein 1 (PRDM1)) and PDRM14, which are expressed during this stage of development. Following specification, PGC founder cells divide in the presence of the DNA methyltransferase DNMT1 and migrate towards the genital ridge. During this migration and on arrival at the genital ridge, 5-methylcytosine (5meC) is erased through an active mechanism. ICM, inner cell mass; TE, trophectoderm.
Primordial germ cell
One of a population of embryonic cells from which germ cells are formed.
At embryonic day 7.5 (E7.5), signals originating from the extraembryonic ectoderm and the visceral endoderm instruct a subset of posterior epiblast cells to become primordial germ cells (PGCs). Specification of PGCs involves the BMP4 and BMP8 signalling pathway and activation of transcription factors BlIMP1 (also known as Pr domain zinc finger protein 1 (PrDM1)) and PrDM14 (ReFs 43, 44) . These founder cells of the germ line begin to migrate at E8.5 and arrive at the genital ridge at E11.5. At the beginning of their specification and migration, PGCs are thought to have the same epigenetic marks as other epiblast cells. However, by the time they arrive at the genital ridge, many of these marks including DNA methyl ation have been erased [45] [46] [47] (FIG. 2b) . Given that PGCs have undergone several cell cycles in the presence of DNMT1, this demethylation event is considered to be active. It is thought that global demethylation, including that of imprinted genes, takes place so that new DNA methyla tion patterns can be reestablished, although experimental evidence supporting this remains to be shown.
Loci-specific active demethylation in somatic cells. Active DNA demethylation has also been reported in somatic cells, but only at specific genomic loci in response to certain signals. For example, within 20 minutes of stimulation, activated T lymphocytes undergo active demethyl ation at the interleukin2 promoterenhancer region in the absence of DNA replication 48 . locusspecific demethyl ation has also been reported to occur at the promoter of brainderived neurotrophic factor (BDNF) 49 , the protein product of which is important for adult neural plasticity (FIG. 3a) . In unstimulated neurons, the BDNF promoter is methylated, allowing for the recruitment of the repres sive meCbinding protein, MeCP2. when depolarized with KCl, BDNF is upregulated, coinciding with the release of MeCP2 and demethylation of the promoter 49 .
Because this event takes place in postmitotic neurons, active demethylation is thought to be the underlying mechanism. In addition to T cells and neurons, active DNA demethylation has been reported to take place dur ing nuclear hormoneregulated gene activation (FIG. 3b) . For example, the pS2 (also known as TFF1) promoter exhibits periodic methylation and demethylation that coincides with cyclical binding of oestrogen receptorα (Erα) and expression of pS2 (ReFs 50, 51) . Similarly, active DNA demethylation occurs at the cytochrome p450, subfamily 27B, polypeptide 1 (CYP27B1) promoter in response to parathyroid hormone (PTH) 52 . These studies suggest that DNA methylation may not function solely as a longterm silencing mark, but could also function in the dynamic regulation of genes that require rapid responses to specific stimuli.
Mechanisms of active DNA demethylation
The importance of DNA methylation in diverse bio logical processes coupled with the observations of active DNA demethylation in embryonic development and somatic cells have led to extensive efforts in identifying DNA demethylases. DNA demethylase activity was first reported in murine erythroleukaemic nuclear extracts 53 .
Although it was determined that 5meC was ultimately replaced by C in a replicationindependent manner, this activity has not been further characterized. A DNA demethylase activity was also seen in rat myoblasts 54 . However, its sensitivities towards rNase and protease treatments were conflicting 55 and this activity was not pursued further.
Since then, several studies have led to the proposal of various mechanisms by which active DNA demethyl ation can occur. These include: enzymatic removal of the methyl group of 5meC, base excision repair (BEr) through direct excision of 5meC, deamination of 5meC to T followed by BER of the T•G mismatch, nucleotide exci sion repair (NEr), oxidative demethylation and radical Sadenosylmethionine (SAM)based demethylation.
Enzymatic removal of the methyl group of 5meC. The simplest way to achieve DNA demethylation is through enzymatic removal of the methyl group of 5meC. This requires an enzyme with enormous catalytic power because of the strength of the carbon-carbon bond that needs to be broken. MethylCpGbinding domain pro tein 2 (MBD2) was the first reported protein to carry out this reaction. It did not require any specific co factors, and was proposed to release methanol 56 . This thermo dynamically unfavourable mechanism was hotly contested for several reasons. First, previous studies had shown that MBD2 can stably bind methylated DNA 57, 58 , making it unclear how binding could occur if MBD2 was so efficient at removing the methyl group. Further concerns were raised when MBD2null mice were not only viable, but also exhibited normal methylation patterns 59 . Importantly, the paternal pro nucleus of MBD2null zygotes still exhibit normal demethylation 31 . These observations, coupled with the fact that no other laboratories could reproduce the reported enzymatic activity, have raised serious doubts on the capacity of MBD2 to serve as a DNA demethylase.
Box 1 | Protection of the maternal genome from demethylation
Whereas the paternal genome undergoes extensive demethylation, the maternal genome remains methylated even though it is exposed to the same cytoplasmic factors. This may be due to a mechanism that protects the maternal genome from this wave of demethylation or to a putative DNA demethylase that is specifically recruited to the paternal genome.
Sperm DNA is packaged with protamines, which are exchanged for canonical and noncanonical histones on fertilization. Interestingly, deposition of the histone variant H3.3 occurs asymmetrically, with a strong preference for the paternal pronucleus 158, 159 . This raises the possibility that asymmetric H3.3 deposition may trigger the paternal genome-specific demethylation process. Asymmetric patterns of histone modifications have also been seen in the maternal and paternal pronuclei and may also contribute to the asymmetric demethylation process. For example, methylation, dimethylation and trimethylation at H3 Lys27 (H3K27me1, H3K27me2 and H3K27me3, respectively) and at Lys9 (H3K9me2 and H3K9me3) are clearly seen in the maternal pronucleus of zygotes, but are virtually undetectable in the paternal pronucleus [159] [160] [161] [162] [163] [164] . Thus, the maternal genome may use a protective mechanism against demethylation by carrying specific histone variants or modifications.
Alternatively, a recent study has suggested that non-histone factors present in the oocyte might protect the maternal genome from demethylation 165 . Zygotes lacking stella (also known as DPPA3 and PGC7), a maternal effect gene required for early development 166 , exhibited demethylation of both pronuclei. Although stella can directly bind DNA in vitro, it seems to lack specificity for methylated DNA 165 . Therefore, how stella protects the maternal genome from demethylation remains to be determined.
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regardless of the controversy surrounding MBD2, it is still conceivable that a bona fide DNA demethylation mechanism exists. In fact, numerous histone demethyl ases that can break a carbon-nitrogen bond have recently been discovered 60, 61 . Although carbon-carbon bonds are inherently more difficult to break than carbon-nitrogen bonds, enzymes that have the capacity to do so have been reported in the thymidine salvage pathway 62 and the c holesterol synthesis pathway 63 .
BER through direct excision of 5meC. It has been pro posed for some time that DNA demethylation can be achieved through the BEr DNA repair pathway (FIG. 4a) . This type of repair involves a DNA glycosylase that removes the target base resulting in an abasic (apurinic and apyrimidinic (AP)) site. The DNA backbone is sub sequently nicked by an AP lyase activity to generate a 5′ phosphomonoester and a 3′ sugar phosphate residue. An AP endonuclease then removes the 3′ sugar group leaving a single nucleotide gap that is ultimately filled in by DNA repair polymerases and ligases 64 . Active DNA demethylation can be accomplished by a DNA glycosylase that directly excises 5meC to initiate BEr (FIG. 4a) . Strong genetic and biochemical evidence supports the use of this mechanism in plants 65 . In Arabidopsis thaliana, DNA demethylation is mediated by the Demeter (Dme) family of DNA glycosylases, which consists of four members: DME, repressor of silencing 1 (roS1; also known as DMl1), DMl2 and DMl3 (ReF. 65) . The discovery that these DNA glyco sylases suppress DNA methylation initially came from forwardgenetic screens in A. thaliana. whereas DME was discovered owing to the loss of expression of the imprinted gene MEDEA in a lossoffunction DME mutant 66 , roS1 was recovered in a genetic screen for mutants that confer promoter hypermethylation and transgene silencing defects 67 . DME, roS1, DMl2 and DMl3 possess glycosylase activity against oligonucleotides containing 5meC [67] [68] [69] [70] [71] . In addition, all members of the Dme family possess AP lyase activity and are thus considered bifunctional glyco sylases [69] [70] [71] . Besides CpG, DNA methylation in plants can occur in the context of CpNpG (where N is A, T or C) and CpNpN. All members of the Dme family have the capacity to recognize and remove meC bases from doublestranded DNA (dsDNA) oligonucleotides, irre spective of their sequence context in vitro 71 . However, attempts to determine the substrate specificity of these enzymes have resulted in conflicting reports owing to the use of different substrates and reaction conditions [68] [69] [70] [71] . In vivo studies indicate that mutation of each of these genes results in hypermethylation in all sequence con texts but at distinct genomic loci 69, [71] [72] [73] , indicating that each of these enzymes has a unique in vivo function.
Although it is clear that plants use BEr to achieve DNA demethylation, evidence supporting a similar mechanism in mammals has been less compelling. Despite the lack of an obvious mammalian orthologue of the roS1 family, the first indication that a repair mechanism could contri bute to DNA demethylation came from early studies in chicken embryo extracts 74 , revealing 5meC glycosylase activity against hemimethylated DNA 75 . Subsequent purification of this activity showed that it has three com ponents: rNA, an rNA helicase related to the human p68 DEADbox protein and a homologue of human T DNA glycosylase (TDG) [76] [77] [78] . Thus, 5meC glycosylase activity initially detected in chicken embryo extracts was attrib uted to TDG. However, its excision activity against 5meC was 30-40fold lower compared with that against T 78 . Although TDG can flip C and C analogues into its active site, it does not possess the catalytic power to break the Nglycosidic bond 79 . It should be noted that the exci sion activity of TDG against 5meC is stimulated by the This demethylation event is considered to be active because it occurs in post-mitotic neurons. b | Active demethylation at nuclear receptor target promoters. The promoter of the oestrogen receptor (ER) target gene pS2 (also known as TFF1) undergoes cyclical rounds of methylation and demethylation that correspond to the repression and expression of the gene, respectively. Transcriptional activation of pS2 occurs in the presence of oestrogens (E2) and coincides with demethylation of the promoter. This is achieved by deamination of 5meC by DNA methyltransferase 3 (DNMT3) followed by base excision repair (BER) of the T•G mismatch by T DNA glycosylase (TDG). To revert to repression, DNMT3 re-methylates the promoter. Although DNMT3 is involved in both methylation and demethylation, it is important to note that DNMT3 can only carry out the deamination step in the absence or at low concentrations of the methyl donor S-adenosylmethionine (SAM).
AP endonuclease DNMTs
Repair synthesis and ligation
RNA editing
The post-transcriptional modification of RNA primary sequence by the insertion and/or deletion of specific bases, or the chemical modification of adenosine to inosine or cytidine to uridine.
Somatic hypermutation
The mutation of the immunoglobulin variable region in mature B cells during an immune response. It results in affinity maturation of the antibody response. Like class switch recombination, it requires activation-induced cytidine deaminase.
presence of both rNA and the rNA helicase 78 . Similarly, both DNMT3A and DNMT3B have been reported to interact with and stimulate the enzymatic activity of TDG 80, 81 . Future work should determine whether these interactions have an effect on substrate preference in vitro and whether loss of function of TDG has an effect on DNA methylation status in vivo.
In addition to TDG, the methylCpGbinding pro tein MBD4 has glycosylase activity against 5meC, but again this activity is 30-40-fold lower than its T•G mismatch glycosylase activity 82 . Not surprisingly, MBD4null zygotes exhibit normal demethylation of the zygotic paternal pronucleus 83 , and MBD4null mice have an increased number of C to T mutations regard less of whether the C is methylated or not 84 . Despite its un favourable biochemical properties, MBD4 was reported to carry out active DNA demethylation of the CYP27B1 promoter in response to PTH 52 . Interestingly, phosphorylation by protein kinase C enhanced MBD4 glyco sylase activity against 5meC 52 , which may par tially explain earlier enzymatic studies showing MBD4's preference for C over 5meC 85 .
Deamination of 5meC to T followed by BER. DNA demethylation can also be achieved by deamination of 5meC to produce T, followed by BEr to replace the mis matched T with unmethylated C (FIG. 4b) . Both cytidine deaminases and DNMTs have been proposed to carry out the first step of this mechanism. on deamination of 5meC, T glycosylases such as TDG and MBD4 (see above) may function by repairing the mismatch.
Cytidine deaminases are important players in diverse biological processes such as the generation of antibody diversity, RNA editing and retroviral defence 86 . These processes require the production of mutations in DNA and rNA, which is achieved, in part, through the deami nation of cytidine to uridine by the activationinduced deaminase (AID) and apolipoprotein B mrNA editing enzyme, catalytic polypeptide (APoBEC) family of pro teins. APoBEC1, the founding member of this family, is involved in editing apolipoprotein B premrNA 87, 88 . The related deaminase AID was discovered to be essential for somatic hypermutation and class switch recombination of immunoglobulin genes in B cells 89, 90 . Consistent with its role in the diversification of antibodies, AIDdeficient . Initiation of the BER pathway can be carried out by a glycosylase that directly excises 5meC to generate an abasic (apurinic and apyrimidinic (AP)) site. The DNA backbone is nicked by an AP lyase (or by the glycosylase itself if it is bifunctional). The 3′ sugar group is then cleaved by an AP endonuclease and the resulting single nucleotide gap is filled in with an unmethylated C by an unknown polymerase and ligase. It has been well established in plants that the demeter (Dme; also known as repressor of silencing 1 (ROS1)) family of enzymes can carry out the 5meC glycosylase reaction, but to date no mammalian enzymes have been reported to be capable of carrying out this step efficiently. b | Deamination of 5meC followed by BER. In contrast to direct excision of 5meC, deamination of 5meC produces T, which can be repaired by BER by a T•G mismatch glycosylase such as T DNA glycosylase (TDG) or methyl-CpG-binding domain protein 4 (MBD4) to regenerate an unmethylated C. DNMT, DNA methyltransferase.
Class switch recombination
A mechanism that changes the class or isotype of antibody produced by an activated B cell. This does not change the affinity towards an antigen, but instead allows for interaction with different effector molecules.
mice are viable and fertile and significant phenotypic abnormalities are seen only in B cells 89, 90 . Despite the lack of developmental defects in AID knockout mice, both AID and APoBEC1 have been shown in vitro and in an E. coli assay to have the capacity to deaminate 5meC to T in the context of singlestranded DNA 91 . AID and APoBEC1 are also expressed in mouse oocytes, ES cells and PGCs, which may be a consequence of their genomic location in a cluster of pluripotency genes that include nanog and stella (also known as DPPA3 and PGC7) 91 . Nevertheless, expression of AID in PGCs and the early embryo points to a possible role in global DNA demethyl ation. Indeed, a recent largescale bisulphite sequencing study indicates that DNA methylation levels of male and female PGCs derived from AIDnull embryos increased about 4% (from 18% to 22%) and 13% (from 7% to 20%), respectively, when compared to their wild type counterpart 92 , suggesting that AID may contribute to PGC demethylation. However, because the DNA methyla tion levels in AIDnull PGCs (~20%) are still relatively low compared with ES or somatic cells (70-80%), considerable demethylation still occurs in the absence of AID, indicat ing that other factors responsible for PGC demethylation remain to be identified.
Nevertheless, studies in zebrafish embryos have suggested that Aid, Mbd4 and the DNA repair protein Gadd45a (growth arrest and DNAdamageinducible 45α) can cooperate in demethylating a methylated DNA duplex 93 . In this study, when a methylated linear dsDNA of ~740 bp was injected into a zebrafish embryo, demeth ylation of the injected DNA was seen when Aid and Mbd4 were coexpressed. The authors postulated that Aid de aminated 5meC, allowing Mbd4 to excise the T•G mismatch. Indeed, the T•G mismatch was detected using a PCr strategy, but only when Aid was expressed with a catalytic mutant of Mbd4 because the wildtype version excised the mismatch too quickly for it to be detected. Furthermore, when Aid and Mbd4 were titrated to levels that did not cause demethylation, the inclusion of Gadd45a elicited demethylation, indicating that these three proteins act cooperatively 93 . Although the above studies have provided some evi dence that AID may contribute to mammalian DNA demethylation, decisive biochemical and genetic evi dence supporting a major role in this process is still lack ing. Biochemically, AID can act on 5meC in the context of singlestranded DNA but not dsDNA 91 . Genetically, AIDknockout mice exhibit the expected B cell and immunological defects 89, 90 , but no gross developmental or reproductive defects. Similarly, APoBEC1knockout mice are also viable and fertile 94, 95 . Although genetic redun dancy may be a possible cause of the lack of expected developmental and reproductive phenotypes, such an explanation needs to be confirmed by generating combi national knockouts. Furthermore, because DNA methyla tion occurs symmetrically, deamination of both strands would give rise to a TG•GT double mismatch. There is no evidence indicating that either TDG or MBD4 can use a double mismatch as a substrate. Furthermore, process ing of a double mismatch by the AP endonuclease would generate a DNA doublestrand break. This would put tremendous pressure on the repair machinery if such a mechanism were used for global demethylation. However, for locusspecific DNA demethylation, such a mechanism would not present a big problem.
In addition to AID and APoBEC, DNMTs have recently been implicated in 5meC deamination, even though they are commonly known for their ability to catalyse DNA methylation. Evidence indicating their involvement in the deamination process initially came from studies in bacteria where the methyltransferases M. HpaII 96-98 and M. EcorII 99,100 were shown to possess deaminase activities. Consistent with bacterial studies, the mammalian counterparts, DNMT3A and DNMT3B, have also been shown to possess deaminase activity in vitro 51 . As discussed above, the promoters of oestro gen responsiv e genes undergo cyclical rounds of methylation and demethylation. Thus, the participation of DNMT3A and DNMT3B in both methylation and demethylation would facilitate rapid transcriptional cycling (FIG. 3b) . Interestingly, Erα associates with and stimulates the activity of TDG 101, 102 , allowing for the repair of the T•G mismatch. DNMT3A and DNMT3B also associate with TDG and this interaction stimulates glycosylase activity 80, 81 . Indeed, DNA demethylation was found to coincide with the recruitment of TDG and other BEr enzymes 51 . However, it is surprising that DNMTs possess two opposing enzymatic activities. Although the methyl transferase activity of DNMT3A is inhibited by TDG 81 , the 5meC deamination reaction can only occur under conditions where SAM concentrations are very low or nonexistent 51 . In order for DNMT3A to carry out efficient methylation and demethylation during transcriptional cycling, levels of SAM must fluctuate rapidly. Given that SAM is crucial for many essential biochemical and bio logical processes, it is difficult to imagine how this could be achieved without serious biological consequences.
Nucleotide excision repair. Another DNA repair path way, NEr, has also been proposed to carry out DNA demethylation. This type of repair is generally used to repair DNA containing bulky lesions, which form after exposure to chemicals or radiation. After damaged DNA is recognized, dual incisions flanking the lesion are made and a 24-32 nucleotide oligomer is released. The result ing gap is then filled in by repair polymerases and sealed by a ligase 64 .
In an assay aimed at identifying proteins required for activation of a reporter that is silenced by DNA methyla tion, Niehrs and colleagues uncovered a novel function for GADD45A group Gcomplementing protein (XPG), which interacts with GADD45A
103
. The recruitment of GADD45A and other components of the NEr repair machinery to ribo somal rNA (rrNA) genes is facilitated by TBPassociated factor 12 (TAF12) and leads to DNA demethylation and rrNA gene activation 107 . However, it is not clear how the demethylation process is initiated and whether GADD45A is directly involved. More importantly, two independent studies have raised doubt on the role of GADD45A in the active DNA demethylation process. In the first study, the Pfeifer group carried out a series of experiments that were similar to those carried out by the Niehrs group, but obtained no evidence indicating that GADD45A had any effect on DNA methylation 108 . In the second study, analysis of the GADD45Anull mice indicated that loss of GADD45A function had neither locispecific nor global effects on DNA methylation levels 109 . GADD45B, another member of the GADD45 family, has also been implicated in active demethylation of genes that are crucial for adult neurogenesis 110 . loss of GADD45B results in defects in neural progenitor pro liferation and dendritic growth. This was attributed to promoter hypermethylation and the repression of BDNF and fibroblast growth factor 1 (FGF1), two genes crucial for neurogenesis 110 . However, GADD45B is not involved in zygotic DNA demethylation as GADD45Bnull zygotes undergo normal paternal genome demethyla tion 111 . Because GADD45B has not been biochemically characterized, it is unknown whether it is directly involved in the active demethylation of neurogenesis genes.
Oxidative demethylation. Another possible mecha nism by which DNA demethylation can be carried out is through oxidative demethylation. The E. coli enzyme AlkB is a member of the 2oxoglutarate (2oG)dependent dioxygenases and is involved in the bacterial response to alkylation damage to DNA. using oxygen, iron and 2oG as cofactors, AlkB is able to carry out oxidative demeth ylation of 1methyladenine and 3meC by releasing the methyl group as formaldehyde 112, 113 . The same mecha nism is used by the JmjC family of enzymes to demethylate histon e substrates 60, 114 . Although breakage of a carbon-carbon bond is ener getically difficult, enzymes that catalyse such reactions do exist. As shown in FIG. 5a , thymine 7hydroxylase can catalyse the conversion of T to isoorotate through three consecutive oxidation reactions using oxygen, iron and 2oG as cofactors 115 . Isoorotate can be further converted to C through a decarboxylation reaction. Although thymine 7hydroxylase and isoorotate decarboxylase have been isolated from fungi, such as Rhodotorula glutinis, Neurospora crassa and Aspergillus nidulans 62 , no homologue of thymine 7hydroxylase has been found in mammals. Interestingly, the trypanosome base J-binding proteins, JBP1 and JBP2, have properties similar to that of thymine 7hydroxylase 116, 117 , prompting the rao group (5meC) involves breaking a carbon-carbon bond, which requires an enzyme with great catalytic power. Such an enzyme exists in the thymidine salvage pathway. Starting with T, thymine-7-hydroxylase (THase) carries out three consecutive hydroxylation reactions to produce iso-orotate, which is processed by a decarboxylase to produce U. A similar mechanism may be used in active DNA demethylation, particularly by the ten-eleven translocation (TET) family of proteins. b | The fate of 5-hydroxymethylcytosine (5hmC). The TET family of proteins catalyses the conversion of 5meC to 5hmC, which may be an intermediate that can be further processed by one of the following mechanisms. BER may be initiated by a 5hmC glycosylase (1); 5hmC may undergo deamination to produce 5hmU (2), which is repaired by BER through a 5hmU glycosylase such as SMUG1 (single-strand-selective monofunctional U DNA glycosylase 1); 5hmC may directly be converted to C by DNA methyltransferases (DNMTs), ultraviolet (UV) exposure or high pH (3); or consecutive hydroxylation reactions followed by a decarboxylation reaction similar to the thymidine salvage pathway may be used to ultimately replace 5hmC with C (4). Alternatively, 5hmC itself may be a functional modification. α-KG, α-ketoglutarate.
to search for mammalian homologues with similarity to the dioxygenase domains of the JBP proteins. This effort led to the identification of the teneleven translocation (TET) family of proteins 118 . we have also independently characterized the mouse TET family 119 . TET1, the founding member of the TET family, was initially discovered in acute myeloid leukaemia (AMl) as a fusion partner of the histone H3 lys4 methyltransferase Mll 120, 121 . Subsequent studies in vitro and in cultured cells showed that human TET1 is capable of hydrolysing 5meC to produce 5hydroxymethylcytosine (5hmC) in DNA 118 . Similarly, all three members of the mouse TET family possess this enzymatic activity 119 . Consistent with the presence of a dioxygenase domain in the proteins and the predicted reaction mechanism, the putative ironbinding sites are required for their enzymatic activi ties 118, 119 . Furthermore, TET1 is capable of acting on both fully methylated and hemimethylated DNA 118 . Although 5hmC has previously been reported to exist in animal DNA 122 , this modified base is not found in some cell types and tissues 118, 123 , thus raising the ques tion of whether 5hmC is present in mammalian DNA at physiologically relevant levels. This issue was directly addressed in two cell types. In Purkinje neurons, 5hmC is ~40% as abundant as 5meC 124 , whereas the frequency of 5hmC in ES cells was estimated to be approximately 1 in every 3,000 nucleotides 118 . Thus, it is evident that 5hmC constitutes a large fraction of mammalian DNA in some cell types.
The consequences of 5hmC in genomic DNA are currently unclear. Because 5hmC seems to be stable, it may function like other modifications by altering local chromatin structure or contributing to the recruitment or exclusion of other factors that influence transcrip tion. For example, the transcriptional repressors MeCP2, MBD1, MBD2 and MBD4 bind to methylated DNA, but do not recognize 5hmC 125, 126 . It is also possible that the TET proteins may facilitate passive demethylation in dividing cells such as ES cells as 5hmC is not recognized by DNMT1 (ReF. 127) ; thus, newly replicated DNA would not maintain patterns of methylation. Alternatively, 5hmC may be an intermediate in an active demethyla tion pathway that ultimately leads to the replacement of 5meC with C (FIG. 5b) . This could be achieved by several ways that include: BEr by a 5hmCspecific DNA glyco sylase (as such activity has been previously reported to exist in calf thymus extracts 128 ), deamination of 5hmC to generate 5hmu followed by BEr initiated by a 5hmu specific glycosylase such as singlestrandselective monofunctional u DNA glycosylase 1 (SMuG1) 129 , conversion of 5hmC to C through loss of formaldehyde on ultraviolet light exposure 130 or high pH 131 (or possi bly carried out by DNMTs) 132 , and two consecutive oxida tion steps followed by decarboxylation similar to that used by the thymidine salvage pathway (FIG. 5a) . It is not clear why TET proteins cannot catalyse consecutive reactions such as that of thymine 7hydroxylase. Because all in vitro assays carried out so far used recombinant TET proteins alone, it is possible that association of TET proteins with their in vivo partners is necessary to con fer such a capability. In this case, a decarboxylase may eventually remove the carboxyl group to complete the demethylation process.
Consistent with the relative enrichment of 5hmC in ES cells, recent studies have shed light on the role of TET1 in ES cell biology. During ES cell differentiation, TET1 mrNA levels decline, coinciding with a decrease in 5hmC levels 118 , which suggests that TET1 may be impor tant for ES cell identity. Indeed, knockdown of TET1, but not TET2 or TET3, in mouse ES cells results in impair ment of ES cell selfrenewal and maintenance 119 . Analysis of the differentiated TET1knockdown ES cells revealed a bias towards the trophoectoderm and primitive endo derm lineages. Furthermore, knockdown of TET1 at twocell stage embryos followed by cell lineage tracing revealed that the knockdown cells are biased towards the trophoectoderm 119 , indicating that TET1 is required for inner cell mass cell specification. Consistent with its role in ES cell selfrenewal and maintenance, knockout of TET1 resulted in embryonic lethality (K. Hong and Y.Z., unpublished observations), making the evaluation of the role of TET1 on global demethylation of the paterna l genome difficult.
with regard to the mechanism underlying the role of TET1 in ES cells, TET1 maintains nanog expression in ES cells by directly binding to the nanog promoter and protecting it from becoming hypermethylated, as knockdown of TET1 in ES cells resulted in downregu lation of nanog expression concomitant with increased nanog promoter methylation 119 . Nanog seems to be one of the main TET1 targets as the phenotypes associated with TET1 knockdown can largely be rescued by ectopic expression of nanog 119 . Although TET2 is also expressed in ES cells, it seems that TET2 does not play a significant part in ES cell biol ogy as knockdown of TET2 does not confer any obvious phenotype 119 . However, a flurry of recent studies have uncovered that dysfunction of human TET2 may be a key event in leukaemogenesis as human TET2 is mutated in a range of human myeloid malignancies, including myelodysplastic syndromes (MDSs), myeloprolifera tive disorders (MPDs) and acute myeloid leukaemias (AMls) [133] [134] [135] [136] [137] [138] [139] [140] . Currently, TET2 is the most frequently mutated gene that has been identified in patients with MDS and these mutations have been suggested to occur early during the pathogenesis of the disease 137 . Consistent with a role for TET2 in regulating DNA demethyla tion, aberrant DNA methylation is frequently found in patients with MDS 141 . Indeed, mutations of TET2 that mimic mutations identified in patients with MDS abol ished the enzymatic activity of TET2 (A. C. D' Alessio and Y.Z., unpublished observations). Furthermore, the DNA methyltransferase inhibitor 5azacytidine (5azaC) has been shown to be an effective treatment for patients with highrisk MDS and secondary AMl 142, 143 , indicating that aberrant DNA methylation plays a crucial part in MDS development and progression. The participation of TET2 in DNA demethylation may provide a molecular basis for the effectiveness of using methyltransferase inhibitors in the treatment of patients with MDS, thus setting the stage for understanding the molecular mechanism under lying the pathogenesis of leukaemias. 
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Elongator complex
A protein complex originally identified in budding yeast to be associated with the elongating and hyperphosphorylated RNA polymerase II. It has also been implicated in tRNA modification, exocytosis and neuronal maturation.
SAM domain
A protein domain containing an Fe-s cluster that uses s-adenosylmethionine (sAM) to catalyse various radical reactions.
Radical SAM mechanism. Although many proteins have been proposed to carry out active DNA demethylation, none of the proteins discussed above have been shown to have a role in paternal genome demethylation in zygotes. To identify proteins involved in paternal genome demethyl ation, our laboratory used a candidate gene knockdown approach coupled with livecell imaging. To facilitate a screen of candidate proteins, we developed a probe that consists of the CysXXCys domain of Mll fused to enhanced green fluorescent protein (EGFP). Because the CysXXCys domain has high affinity for unmethylated CpG 144 , injection of mrNA encoding the probe into zygotes results in the accumulation of the probe at the demethylated paternal pronucleus 111 , allowing livecell imaging of the paternal genome demethylation process. using this imaging system, we screened several candidate proteins by injecting small interfering rNAs (sirNAs) against each of the candidates into eggs before carrying out intracytoplasmic sperm injection (ICSI), and monitored the effect of the sirNA on the accumu lation of the probe at the paternal pronucleus. This screen uncovered a role for elongator complex protein 3 (ElP3) in paternal genome demethylation. ElP3 is a member of the core elongator complex (ElP1-ElP3), which combines with another subcomplex (ElP4-ElP6) to form the holoelongator complex 145, 146 . Because knockdown of the ElP1 and ElP4 components also impaired paternal genome demethylation, it is likely that the entire elongator complex may be involved in the demethylation process 111 . Interestingly, the Fe-S radical sAM domain of ElP3, but not the histone acetyltransferase (HAT) domain, is required for paternal genome demethyl ation 111 . Although this may provide a clue regarding the enzymatic mechanism of ElP3, recent studies in yeast suggest that the Cysrich domain of Elp3 is required for the integrity of the elongator complex 147, 148 , raising the possibility that the Fe-S radical SAM motif may have a structural rather than an enzymatic role. Thus, direct biochemical evidence of the enzymatic activity of the elongator complex and genetic evidence using ElP3null oocytes remain to be shown.
Interestingly, a recent study confirmed the presence of an Fe-S cluster in the bacteria Methanocaldococcus jannaschii Elp3 protein 149 . The assumption that mammal ian ElP3 is a radical SAM protein has led to a potential mechanism for ElP3catalysed DNA demethylation as outlined in FIG. 6 (S. J. Booker, personal communication) . contains an Fe-S radical S-adenosylmethionine (SAM) domain that is important for active DNA demethylation of the zygotic paternal genome. If ELP3 is indeed a functional radical SAM protein, it may directly carry out DNA demethylation through the following mechanism. First, ELP3 uses SAM to generate a 5′-deoxyadenosyl radical, which could extract a hydrogen atom from the 5-methyl group of 5-methylcytosine (5meC; 1) to form a 5meC radical (2) . After an electron is donated back to the Fe -S to create the third intermediate (3), a water molecule would promote the formation of 5-hydroxymethylcytosine (5hmC) (4) . A nucleophilic attack at carbon 6 can result in the carbon-carbon bond breaking to release formaldehyde (5-7). In the absence of an external nucleophile, an alternative pathway (4′-6′) that leads to the release of formaldehyde can also take place. Finally, an elimination step would produce an end product of C (8).
like every radical SAM enzyme, the reaction is initiated by the generation of a powerful oxidizing agent, the 5′deoxyadenosyl (5′dA) radical, from SAM. The 5′dA radical could extract a hydrogen atom from the 5methyl group to generate a 5meC radical. In the next step, an electron is returned back to the Fe-S cluster to generate a third intermediate, which can be converted to the rela tively stable 5hmC by the addition of a water molecule. In order to break the carbon-carbon bond, the next step requires the generation of an intermediate, the resulting carbanion of which would be stabilized. This can prob ably be achieved by a thymidylate synthase or methyl transferase type of mechanism, whereby a Cys residue carries out a nucleophilic attack at carbon 6, leading to the release of formaldehyde. In the absence of an external nucleophile, an alternative pathway leading to the release of formaldehyde can also take place. Finally, an elimina tion at the formaldehyde release step results in the final product of C.
Although future studies are required to validate or refute this proposed mechanism, we note that this work is not trivial for three reasons. First, the identities of mam malian ElP5 and ElP6 still need to be determined as an apparent orthologue of yeast Elp5 and Elp6 cannot be iden tified by sequence homology searches. Second, the radical SAM reaction occurs under anaerobic conditions and reconstitution of the elongator complex under anaerobic conditions is challenging. Finally, given that zygotic DNA demethylation occurs only on the paternal genome, some unique features of the paternal genome may be required in order for it to serve as a substrate. Despite these challenges, identification of the elongator complex as an important factor for paternal genome demethylation in zygotes allows for further studies towards understanding the molecular mechanisms of active DNA demethylation.
Concluding remarks
observations of active DNA demethylation during embryonic development and in somatic cells have opened the door for many questions to be answered. In particular, how DNA demethylation is achieved in mammalian cells remains debatable as no single enzyme or mechanism has gained decisive biochemical and genetic support (see Supplementary information S1 (table)). It is possible that multiple mechanisms exist to carry out DNA demethyla tion and that the use of each one is dictated by the specific biological context.
Although repairbased mechanisms, particularly deamination of 5meC followed by BEr, have offered an attractive mechanism for active DNA demethyla tion, genetic evidence is still lacking. Furthermore, the involvement of a repairbased mechanism in global DNA demethylation would put tremendous pressure on the repair machinery when considering that paternal pro nucleus demethylation is completed within 4 hours 17, 18 . Although AID seems to contribute to active demethyla tion in PGCs, it is only responsible for a small part of it as considerable demethylation still takes place in the AID null PGCs 92 . Nevertheless, this mechanism does provide a reasonable explanation for locispecific demethylation in response to geneactivation signals.
Although AID deficiency has some effect on PGC demethylation, there is no evidence that it affects paternal DNA demethylation in zygotes. Similarly, MBD4null zygotes still experience paternal genome demethyla tion 83 . It seems that although repairbased mechanisms may be responsible for locispecific DNA demethylation and partial demethylation in PGCs, their role in zygotic paternal genome demethylation is less likely. To date, the only factor shown to have a role in zygotic paternal genome demethylation is the elongator complex, although it is unclear whether its role is direct or indirect 111 . Future work should focus on gaining additional genetic evidence using elongatornull zygotes and elucidating its enzymatic activity. The recent demonstration that the TET family proteins are capable of catalysing the conversion of 5meC to 5hmC has raised the possibility that these proteins may have a role in active DNA demethylation 118, 119 . we anti cipate that work evaluating their role in demethylation of the zygotic paternal genome and PGCs is forthcoming. Furthermore, analysis of the fate and function of 5hmC will also attract a lot of attention.
In addition to determining the mechanism of active demethylation, one open question that remains is to what extent the paternal genome and PGCs are demethylated. Although this event is considered to be global, as deter mined by 5meC immunostaining, it is evident that some regions of the paternal genome are protected from this wave of demethylation. The advent of highthroughput analyses including chromatin immunoprecipitation onchip (ChIPchip), ChIP sequencing (ChIPSeq) and bi sulphite sequencing (BSSeq; bisulphite treatment Box 2 | Implications of active DNA demethylation in reprogramming Induced pluripotent stem (iPS) cells can be generated by introducing four transcription factors -octamer-binding protein 3 (OCT3; also known as OCT4 and POU5F1), SRY box-containing factor 2 (SOX2), krüppel-like factor 4 (KLF4) and MYC -into somatic cells 167, 168 . Successful reprogramming requires the activation of endogenous OCT4 and nanog genes, which are known to be silenced by DNA methylation in somatic cells [169] [170] [171] [172] . Demethylation of the OCT4 and nanog promoters is thus an integral event in iPS cell generation 173 . In fact, inefficient DNA demethylation is thought to be one of the causes of the low efficiency in iPS cell generation because the use of the DNA methylation inhibitor 5-azacytidine can increase the efficiency of iPS cell generation by converting partially reprogrammed cells to fully reprogrammed iPS cells 173 . Transcription factor-based iPS cell generation is a slow process compared to somatic cell nuclear transfer (SCNT) and cell fusion 174, 175 . One possible explanation for this difference may be the mechanisms used to reactivate endogenous OCT4 and nanog. Epigenetic reprogramming of somatic cells to pluripotent iPS cells may necessitate several cell divisions 176 owing to the absence of the DNA demethylase or demethylases required for demethylation of the OCT4 and nanog promoters. By contrast, reactivation of OCT4 and nanog can occur quickly during SCNT and cell fusion because the DNA demethylase or demethylases may already be present in eggs and embryonic stem (ES) cells. Consistent with this notion, reprogramming by cell fusion requires activation-induced deaminase (AID)-dependent demethylation and reactivation of OCT4 and nanog 177 . Surprisingly, although AID was present at the OCT4 and nanog promoters in fibroblasts, these promoters are methylated, suggesting that other factors or regulatory events are required for demethylation. Given that genetic evidence does not support an important role for AID in ES cells (see main text), it is unclear whether AID directly participates in promoter demethylation of these genes during somatic cell reprogramming. Regardless, it is evident that activation of pluripotent genes through DNA demethylation is an important step during the somatic cell reprogramming process. Identification and characterization of the enzymes involved should improve protocols of somatic cell reprogramming.
followed by highthroughput sequencing) has allowed for genomewide profiling of epigenetic marks such as DNA methylation 92, [150] [151] [152] [153] . using singlemolecule, real time sequencing, a recent study showed the feasibility of direct detection of modified nucleotides in DNA, includ ing N6meA, 5mC and 5hmC 154 . Future studies using these tools will undoubtedly determine precisely which genomic regions are demethylated and which regions are protected. However, improvements in the sensitivity of these technologies will be necessary for such experi ments, given that paternal genomic DNA would need to be obtained from individual zygotes.
As well as being fundamental to our knowledge in epi genetics, a better understanding of how DNA demethyla tion occurs will allow for the development of techniques and approaches that will improve somatic cell reprogram ming (BOX 2) and cancer treatment. Tumour suppressor gene silencing by promoter DNA methylation is thought to play an important part in cancer development 155 .
Consistently, inhibitors of DNMTs have been used in the treatment of certain cancers 156 . owing to the revers ible nature of epigenetic modifications, developing drugs that target epigenetic factors is becoming one of the top priorities for many biotechnology and pharma ceutical companies 157 . It is anticipated that targeted demethylation of tumour suppressor genes may reactivate the silenced tumour suppressor genes, which can lead to cellular dif ferentiation or halt uncontrolled cell proliferation.
The mechanism underlying the regulation of DNA methylation is a question that has elicited much attention and controversy over the past decade. Although recent studies have proposed numerous ideas as to how active DNA demethylation is carried out, many aspects are still contentious and a consensus has yet to be achieved. with the development of new technology and the studies described above, our continued and collective efforts in this field will hopefully provide clearer answers in the coming decade.
